One of the entities included in this category is the TFEB-altered renal cell carcinoma, initially included in the 2016 WHO classification as a member of the microphthalmia (MiT/TFE) transcription factor family translocation carcinomas. Here, TFEB is linked to hereditary clear cell renal cell carcinoma.